CBFβ-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interaction.

Saved in:
Bibliographic Details
Title: CBFβ-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interaction.
Authors: Kamel EM; Chemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef 62514, Egypt., Khadrawy SM; Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia., Ali MAM; Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia., Ahmed NA; Physiology Division, Zoology Department, Faculty of Science, Beni-Suef University, P.O. Box 62521, Beni-Suef, Egypt. Electronic address: drnohascience@science.bsu.edu.eg., Alkhedhairi S; Department of Medical Biosciences, College of Veterinary Medicine, Qassim University, P.O. Box 6622, Buraydah 51452, Saudi Arabia., Aba Alkhayl FF; Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia., Lamsabhi AM; Departamento de Química and Institute for advanced research in chemical Science (IAdChem), Facultad de Ciencias, Universidad Autónoma de Madrid, Módulo 13, Madrid 28049, Spain.
Source: Pathology, research and practice [Pathol Res Pract] 2026 Jul 01; Vol. 286, pp. 156607. Date of Electronic Publication: 2026 Jul 01.
Publication Type: Journal Article; Review
Journal Info: Publisher: Gustav Fischer Verlag Country of Publication: Germany NLM ID: 7806109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-0631 (Electronic) Linking ISSN: 03440338 NLM ISO Abbreviation: Pathol Res Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1618-0631
DOI:10.1016/j.prp.2026.156607